These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 32391556)

  • 21. Characterization of a potent and highly unusual minimally enhancing antibody directed against dengue virus.
    Renner M; Flanagan A; Dejnirattisai W; Puttikhunt C; Kasinrerk W; Supasa P; Wongwiwat W; Chawansuntati K; Duangchinda T; Cowper A; Midgley CM; Malasit P; Huiskonen JT; Mongkolsapaya J; Screaton GR; Grimes JM
    Nat Immunol; 2018 Nov; 19(11):1248-1256. PubMed ID: 30323338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dengue Antibody and Zika: Friend or Foe?
    Durbin AP
    Trends Immunol; 2016 Oct; 37(10):635-636. PubMed ID: 27599407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A conceptual model for optimizing vaccine coverage to reduce vector-borne infections in the presence of antibody-dependent enhancement.
    Tang B; Huo X; Xiao Y; Ruan S; Wu J
    Theor Biol Med Model; 2018 Sep; 15(1):13. PubMed ID: 30173664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Why are dengue virus serotypes so distantly related? Enhancement and limiting serotype similarity between dengue virus strains.
    Kawaguchi I; Sasaki A; Boots M
    Proc Biol Sci; 2003 Nov; 270(1530):2241-7. PubMed ID: 14613610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody-dependent enhancement of dengue virus infection is inhibited by SA-17, a doxorubicin derivative.
    Ayala-Nuñez NV; Jarupathirun P; Kaptein SJ; Neyts J; Smit JM
    Antiviral Res; 2013 Oct; 100(1):238-45. PubMed ID: 23994499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Controversy over dengue vaccine risk.
    Cohen J
    Science; 2019 Sep; 365(6457):961-962. PubMed ID: 31488666
    [No Abstract]   [Full Text] [Related]  

  • 27. Antibody-Dependent Enhancement and Zika: Real Threat or Phantom Menace?
    Martín-Acebes MA; Saiz JC; Jiménez de Oya N
    Front Cell Infect Microbiol; 2018; 8():44. PubMed ID: 29497604
    [No Abstract]   [Full Text] [Related]  

  • 28. Can we find a possible structural explanation for antibody-dependent enhancement of dengue virus infection resulting in hemorrhagic fever?
    Mikita CP; Padlan EA
    Med Hypotheses; 2016 Mar; 88():49-52. PubMed ID: 26880637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody-dependent enhancement of infection and the pathogenesis of viral disease.
    Morens DM
    Clin Infect Dis; 1994 Sep; 19(3):500-12. PubMed ID: 7811870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substitution of the precursor peptide prevents anti-prM antibody-mediated antibody-dependent enhancement of dengue virus infection.
    Wang Y; Si LL; Guo XL; Cui GH; Fang DY; Zhou JM; Yan HJ; Jiang LF
    Virus Res; 2017 Feb; 229():57-64. PubMed ID: 27939945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paradoxical role of antibodies in dengue virus infections: considerations for prophylactic vaccine development.
    Acosta EG; Bartenschlager R
    Expert Rev Vaccines; 2016; 15(4):467-82. PubMed ID: 26577689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.
    Sasaki T; Setthapramote C; Kurosu T; Nishimura M; Asai A; Omokoko MD; Pipattanaboon C; Pitaksajjakul P; Limkittikul K; Subchareon A; Chaichana P; Okabayashi T; Hirai I; Leaungwutiwong P; Misaki R; Fujiyama K; Ono K; Okuno Y; Ramasoota P; Ikuta K
    Antiviral Res; 2013 Jun; 98(3):423-31. PubMed ID: 23545366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoxia enhances antibody-dependent dengue virus infection.
    Gan ES; Cheong WF; Chan KR; Ong EZ; Chai X; Tan HC; Ghosh S; Wenk MR; Ooi EE
    EMBO J; 2017 May; 36(10):1348-1363. PubMed ID: 28320741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary human endothelial cells support direct but not antibody-dependent enhancement of dengue viral infection.
    Arévalo MT; Simpson-Haidaris PJ; Kou Z; Schlesinger JJ; Jin X
    J Med Virol; 2009 Mar; 81(3):519-28. PubMed ID: 19152413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response to dengue fever--the good, the bad, and the ugly?
    Schmidt AC
    N Engl J Med; 2010 Jul; 363(5):484-7. PubMed ID: 20818870
    [No Abstract]   [Full Text] [Related]  

  • 36. The mechanistic role of antibodies to dengue virus in protection and disease pathogenesis.
    Gan ES; Ting DH; Chan KR
    Expert Rev Anti Infect Ther; 2017 Feb; 15(2):111-119. PubMed ID: 27796143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dengue virus specific IgY provides protection following lethal dengue virus challenge and is neutralizing in the absence of inducing antibody dependent enhancement.
    Fink AL; Williams KL; Harris E; Alvine TD; Henderson T; Schiltz J; Nilles ML; Bradley DS
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005721. PubMed ID: 28686617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dramatic caspase-dependent apoptosis in antibody-enhanced dengue virus infection of human mast cells.
    Brown MG; Huang YY; Marshall JS; King CA; Hoskin DW; Anderson R
    J Leukoc Biol; 2009 Jan; 85(1):71-80. PubMed ID: 18809735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chaotic desynchronization of multistrain diseases.
    Schwartz IB; Shaw LB; Cummings DA; Billings L; McCrary M; Burke DS
    Phys Rev E Stat Nonlin Soft Matter Phys; 2005 Dec; 72(6 Pt 2):066201. PubMed ID: 16486034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum.
    Valiant WG; Mattapallil JJ
    J Vis Exp; 2018 Apr; (134):. PubMed ID: 29708542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.